Cipla unveils new products to combat Malaria, HIV/AIDS

“We are increasing our private market investment portfolio to new seven products by the end of the financial year 2023/2024,” Ajay said.

PREMIUM Health

Executive Chairman of CIPLA Industries Limited Emmanuel Katongole (left) interacts with Chief Executive Officer Ajay Kumar Pal after the stakeholders breakfast meeting. (Photos by Francis Emorut)
By NewVision Reporter
Journalists @NewVision
#HIV/AIDS #Malaria #Combat products #To be released #Cipla Quality Chemical Industries #Ajay Kumar Pal

_______________________

Cipla Quality Chemical Industries is set to launch new medical products on the market to combat HIV/AIDS, malaria, hypertension, and diabetes.

The revelation was made by the

Login to begin your journey to our premium content